Chartwell Molecules Company Profile

What is the competitive landscape for CHARTWELL MOLECULES, and what generic and branded alternatives to CHARTWELL MOLECULES drugs are available?

CHARTWELL MOLECULES has twenty-one approved drugs.

Summary for Chartwell Molecules

US Patents:	0
Tradenames:	16
Ingredients:	16
NDAs:	21

Drugs and US Patents for Chartwell Molecules

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Chartwell Molecules	ACYCLOVIR	acyclovir	TABLET;ORAL	074834-001	Apr 24, 1997		DISCN	No	No
Chartwell Molecules	NAPROXEN	naproxen	TABLET;ORAL	074410-001	Apr 28, 1995		DISCN	No	No
Chartwell Molecules	SULFAMETHOXAZOLE AND TRIMETHOPRIM	sulfamethoxazole; trimethoprim	TABLET;ORAL	078060-001	Jan 25, 2007	AB	RX	No	No
Chartwell Molecules	DILTIAZEM HYDROCHLORIDE	diltiazem hydrochloride	TABLET;ORAL	074093-002	Nov 5, 1992		DISCN	No	No
Chartwell Molecules	NILSTAT	nystatin	SUSPENSION;ORAL	050299-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No
Chartwell Molecules	CLONIDINE HYDROCHLORIDE	clonidine hydrochloride	TABLET;ORAL	071785-003	Apr 5, 1988	AB	RX	No	No
Chartwell Molecules	DILTIAZEM HYDROCHLORIDE	diltiazem hydrochloride	TABLET;ORAL	074093-004	Nov 5, 1992		DISCN	No	No

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Chartwell
• Chartwell Injectable
• Chartwell Molecular
• Chartwell Molecules
• Chartwell Pharma
• Chartwell Rx
• Chartwell Tetra